“BioCatch’s approach here is notable for not needing to rely on specialized hardware, making it another one of the many behavioral metrics – the company says it uses 2,000 of them – that can be analyzed by BioCatch’s technology via a software-based approach.”

BioCatch has further solidified its IP holdings with a newly granted patent, its 39th in the US.

The new patent covers one particular aspect of BioCatch’s behavioral biometrics platform: Methods of assessing the level of pressure that a user applies to a given touchscreen or other electronic system. BioCatch’s approach here is notable for not needing to rely on specialized hardware, making it another one of the many behavioral metrics – the company says it uses 2,000 of them – that can be analyzed by BioCatch’s technology via a software-based approach.

In a statement announcing the patent approval, BioCatch executives explained its importance with respect to the company’s larger business model. “The company’s IP portfolio is far and away the most robust amongst the behavioral biometrics players,” said Business Development VP and CTO Avi Turgeman. “Our patent work began in 2010, at a time when others in the security industry were just becoming aware of threats like Remote Access Attacks (RATs), Man-in-the-Browser (MitB) Trojans, and so forth.”

“Patents and other types of intellectual property have long been synonymous with client and shareholder value, as a measure of a company’s commitment to continued innovation and market leadership,” added CEO Howard Edelstein.

In addition to its portfolio of 39 patents granted by the United States Patent and Trademark Office, BioCatch says it also has 25 patent applications awaiting approval.